101 related articles for article (PubMed ID: 33489707)
1. First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with
Ono Y; Takada K; Osoegawa A; Kinoshita F; Oba T; Tsukamoto S; Tagawa T; Oda Y; Mori M
Int Cancer Conf J; 2021 Jan; 10(1):78-82. PubMed ID: 33489707
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Leptomeningeal Metastases in a Patient with Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation.
Niu H; Zhou J; Maan H; Markman M; Niu J
Case Rep Oncol; 2017; 10(3):840-845. PubMed ID: 29070999
[TBL] [Abstract][Full Text] [Related]
3. Salvage therapy of osimertinib plus anlotinib in advanced lung adenocarcinoma with leptomeningeal metastasis: A case report.
Wu K; Fu Y; Gao Z; Jiang J
Respir Med Case Rep; 2022; 38():101682. PubMed ID: 35707406
[TBL] [Abstract][Full Text] [Related]
4. Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review.
Zhong W; Wu L; Huang L; Wang J; Shi H; Wu S
Front Oncol; 2024; 14():1377451. PubMed ID: 38711856
[TBL] [Abstract][Full Text] [Related]
5. Early detection of circulating tumor DNA and successful treatment with osimertinib in thr790met-positive leptomeningeal metastatic lung cancer: A case report.
Xu LQ; Wang YJ; Shen SL; Wu Y; Duan HZ
World J Clin Cases; 2022 Aug; 10(22):7968-7972. PubMed ID: 36158482
[TBL] [Abstract][Full Text] [Related]
6. Osimertinib administration via nasogastric tube in an EGFR-T790M-positive patient with leptomeningeal metastases.
Takeda T; Itano H; Takeuchi M; Nishimi Y; Saitoh M; Takeda S
Respirol Case Rep; 2017 Jul; 5(4):e00241. PubMed ID: 28469919
[TBL] [Abstract][Full Text] [Related]
7. Acquired L718V/
Schultz É; Pencreach E; Rimelen V; Palama A; Holder É; Gantzer J; Bender L
Ann Transl Med; 2023 Mar; 11(5):223. PubMed ID: 37007549
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
[TBL] [Abstract][Full Text] [Related]
9. Treatment response to osimertinib in a patient with leptomeningeal metastasis from lung adenocarcinoma following failure of gefitinib and erlotinib: A case report.
Li J; Liu X; Yuan C
Mol Clin Oncol; 2018 Sep; 9(3):321-324. PubMed ID: 30112177
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of Clinicopathological Feature and Prognosis for
Leptomeningeal Metastasis in Non-small Cell Lung Cancer].
Zhu M; Ren Y; Liu Y; Ban C; Gu H; Wang Z; Zhang Y
Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):533-8. PubMed ID: 27561804
[TBL] [Abstract][Full Text] [Related]
11. Successful therapy using high-dose furmonertinib for non-small cell lung cancer with leptomeningeal metastasis: a case report and literature review.
Chen T; Chen J; Liu DS; Shu YL; Fu MY; Gou HJ; Lei KJ; Jia YM
Front Oncol; 2023; 13():1233198. PubMed ID: 37920163
[TBL] [Abstract][Full Text] [Related]
12. Effective Treatment With Afatinib of Lung Adenocarcinoma With Leptomeningeal Metastasis Harboring the Exon 18 p.G719A Mutation in the EGFR Gene Was Detected in Cerebrospinal Fluid: A Case Report.
Ma C; Wang S; Mu N; Li J; Liu M; Li L; Jiang R
Front Oncol; 2020; 10():1635. PubMed ID: 33014823
[No Abstract] [Full Text] [Related]
13. Bone Metastasis of Non-Small-Cell Lung Cancer Showing Pathological Complete Response to Osimertinib Monotherapy.
Shintani H; Oura S; Yamaguchi T; Makimoto S
Case Rep Oncol; 2021; 14(3):1876-1881. PubMed ID: 35111023
[TBL] [Abstract][Full Text] [Related]
14. Influence of the Timing of Leptomeningeal Metastasis on the Outcome of
Liao PY; Ou WF; Su KY; Sun MH; Huang CM; Chen KC; Hsu KH; Yu SL; Huang YH; Tseng JS; Yang TY; Chang GC
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740489
[TBL] [Abstract][Full Text] [Related]
15. Band-Like Brainstem Lesion in a Patient With a History of Lung Adenocarcinoma.
Obara K
Cureus; 2022 Oct; 14(10):e30726. PubMed ID: 36320789
[TBL] [Abstract][Full Text] [Related]
16. Treatment Response To Osimertinib In
Li H; Yu T; Huang M; Guo A; Qian X; Yin Z
Onco Targets Ther; 2019; 12():7785-7790. PubMed ID: 31571928
[TBL] [Abstract][Full Text] [Related]
17. Increasing discrepancy of MR imaging and CSF study in patients with leptomeningeal seeding from lung adenocarcinoma after targeted therapy using a tyrosine kinase inhibitor.
Seong M; Park S; Kim ST; Goo Park S; Kim Y; Cha J; Yeop Kim E; Kim HJ; Ahn MJ
Medicine (Baltimore); 2023 Oct; 102(40):e35387. PubMed ID: 37800766
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer.
Wu YL; Zhao Q; Deng L; Zhang Y; Zhou XJ; Li YY; Yu M; Zhou L; Zou BW; Lu Y; Liu YM
Lung Cancer; 2019 Jan; 127():1-5. PubMed ID: 30642536
[TBL] [Abstract][Full Text] [Related]
19. Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis.
Yan W; Liu Y; Li J; Han A; Kong L; Yu J; Zhu H
Radiat Oncol; 2019 Sep; 14(1):168. PubMed ID: 31521171
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and
Zhao J; Zou M; Lv J; Han Y; Wang G; Wang G
Onco Targets Ther; 2018; 11():5545-5550. PubMed ID: 30233215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
